кредитный займ на карту
Home » Business

Market Movers : Bristol-Myers Squibb Company (NYSE:BMY), Walgreen Co. (NYSE:WAG), Duke Realty Corporation (NYSE:DRE), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), SunEdison, Inc. (NYSE:SUNE)

Written by on October 20, 2014

Bristol-Myers Squibb Company (NYSE:BMY) announced that it will host a teleconference on Friday, October 31, 2014, at 2:30 p.m. EDT (1:30 p.m. CDT) to review data presented at the Chicago Multidisciplinary Symposium on Thoracic Oncology (CMSTO) in Chicago. Bristol-Myers Squibb Company (NYSE:BMY)’s stock on 17 October traded at beginning with a price of $49.57 and when day-trade ended the stock finally moved up 2.44% to end at $50.42. Bristol-Myers Squibb Company (NYSE:BMY)’s showed weekly performance of 0.28%.

On October 17, Walgreen Co. (NYSE:WAG)’s former chief financial officer Wade Miquelon on Thursday slapped the drugstore chain with a defamation suit in an Illinois county court, saying Walgreen’s top brass leaked false reports to the press that he was forced to resign after he “bungled” an earnings forecast. Walgreen Co. (NYSE:WAG) on Friday closed at $60.27. Stock institutional ownership is 67.40% while insider ownership includes 0.10%. Walgreen Co. (NYSE:WAG) distance from 50-day simple moving average (SMA50) is -1.94%.

On October 9, Duke Realty Corporation (NYSE:DRE) a leading industrial, suburban and medical office property REIT, announced that it has closed a $1.2 billion unsecured revolving credit facility which replaces its existing $850 million facility that was set to mature in December 2015. Duke Realty Corporation (NYSE:DRE)’s shares on Friday traded in the range of 17.66 – 18.00and ended up on $17.83. Duke Realty Corporation (NYSE:DRE) distance from 200-day simple moving average (SMA200) is 4.22%. DRE’s sales growth for past 5 years was -2.70% and its EPS growth for past 5 years was -20.80%.

On October 15, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) currently carries Wall Street consensus rating of a “hold” and price objective of $5.06. That reflects the views of seven firms that are presently covering the stock. Some of the prominent firms currently covering SNSS include Roth Capital and RBC Capital. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)’s stock on 17 October moved up 5.88% to the closing price of $1.44. Its fifty two weeks range is $1.00 – 8.46. The total market capitalization recorded $87.0M. Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) monthly performance is -80.54%.

On October 15, Sunedison Inc (NYSE:SUNE) announced that the company’s credit facility cap has increased from $400 million to $800 million. An increase in credit facility cap reflects that banks are exhibiting confidence in the Maryland Heights, Missouri-based silicon wafer manufacturing company. SunEdison, Inc. (NYSE:SUNE) on Friday closed at $16.62. Stock institutional ownership is 82.00% while insider ownership includes 0.50%. SunEdison, Inc. (NYSE:SUNE) distance from 50-day simple moving average (SMA50) is -17.40%.